Jan Hauser - 31 Oct 2021 Form 4 Insider Report for Enfusion, Inc.

Role
Director
Signature
/s/ Blake Nielsen, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
31 Oct 2021
Net transactions value
$0
Form type
4
Filing time
02 Nov 2021, 18:08:28 UTC
Previous filing
21 Oct 2021
Next filing
16 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +11,029 $0.000000 11,029 31 Oct 2021 Direct F1
transaction ENFN Class A Common Stock Award $0 +5,515 +50% $0.000000 16,544 31 Oct 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units vest as follows: 3,676 RSUs on September 27, 2022; 3,676 RSUs on September 27, 2023; and 3,677 RSUs on September 27, 2024.
F2 Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units will vest in full on the date of the 2022 annual meeting of stockholders of the issuer.